Successful Treatment of Vancomycin-Resistant Enterococci Peritonitis with Quinupristin/Dalfopristin in a Patient on Continuous Ambulatory Peritoneal Dialysis |
Jung-Im Jung, Su-Jin Kim, Byoung-Hoon Ji, Joon-Seok Oh, Sung-Min Kim, Yong-Hun Sin, Joong-Kyung Kim |
|
지속성 외래 복막 투석 환자의 반코마이신 내성 장구균 복막염 치료 1예 |
정정임, 김수진, 지병훈, 오준석, 김성민, 신용훈, 김중경 |
|
|
|
Abstract |
Peritonitis is one of the major complications of continuous ambulatory peritoneal dialysis (CAPD). Multidrug-resistant organisms, including vancomycin-resistant enterococci (VRE), have been reported as pathogens of CAPD-associated peritonitis. The incidence of hospital-associated infections caused by VRE has recently increased. Some drugs, such as linezolid and quinupristin/dalfopristin, have been introduced as treatments of VRE infection. However, there is limited information about the effects of VRE-associated CAPD peritonitis. We present a case of successful treatment of CAPD peritonitis caused by VRE with quinupristin/dalfopristin and include a review of the literature. |
Key Words:
Vancomycin-resistant enterococcus infection; Peritoneal dialysis, Continuous ambulatory; Peritonitis; Quinupristin/dalfopristintin |
|